Related Experiment Video
Updated: Apr 19, 2026

09:33
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
29.5K
Microstructural white matter changes underlying cognitive and behavioural impairment in ALS--an in vivo study using
Elisabeth Kasper1, Christina Schuster2, Judith Machts3
1Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany.
Plos One
|December 16, 2014
Summary
Diffusion tensor imaging (DTI) reveals white matter changes in amyotrophic lateral sclerosis (ALS) patients with cognitive impairment, particularly in frontal regions. These microstructural alterations correlate with executive and memory deficits.
Area of Science:
- Neuroimaging
- Neuroscience
- Neurology
Background:
- Amyotrophic lateral sclerosis (ALS) frequently presents with frontotemporal cognitive and behavioral disturbances.
- Executive functioning and behavioral control are often impaired.
- Previous structural imaging studies in ALS did not consistently assess cognitive status.
Purpose of the Study:
- To investigate microstructural white matter changes associated with cognitive impairment in ALS patients using diffusion tensor imaging (DTI).
- To correlate DTI findings with neuropsychological and behavioral measures.
Main Methods:
- Assessed 72 non-demented ALS patients and 65 healthy controls with a comprehensive neuropsychological test battery and DTI.
- Compared DTI measures of fiber tract integrity using tract-based spatial statistics across patient and control groups.
- Correlated neuropsychological and behavioral measures with DTI findings.
Main Results:
- ALS patients without cognitive impairment showed white matter changes primarily in motor tracts.
- Approximately 30% of ALS patients exhibited additional white matter alterations in extra-motor, particularly frontal, regions.
- Impaired executive and memory functions correlated with white matter integrity in association tracts.
Conclusions:
- DTI can detect differences in white matter integrity between cognitively unimpaired and impaired ALS patients.
- Microstructural white matter changes in non-demented, cognitively impaired ALS patients are linked to executive and memory dysfunction, involving prefrontal and temporal areas.
More Related Videos
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
2
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
2
Alzheimer Disease l: Introduction
4
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
4
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Dementia l: Introduction
3
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
3

